Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramanadham

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|July 11, 1997
Interleukin-1 reduces the glycolytic utilization of glucose by pancreatic islets and reduces glucokinase mRNA content and protein synthesis by a nitric oxide-dependent mechanismZ Ma, M Landt, A Bohrer, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Vanadium and diabetes]G Cros, J J Mongold, J J Serrano, et al.
Biological Trace Element Research|August 1, 1991
The distribution and half-life for retention of vanadium in the organs of normal and diabetic rats orally fed vanadium(IV) and vanadium(V)S Ramanadham, C Heyliger, M J Gresser, et al.
Canadian Journal of Physiology and Pharmacology|April 1, 1990
Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulinS Ramanadham, G H Cros, J J Mongold, et al.
Metabolism: Clinical and Experimental|October 1, 1989
Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatmentS Ramanadham, R W Brownsey, G H Cros, et al.
Lipids|September 13, 2000
Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty ratsF F Hsu, A Bohrer, M Wohltmann, et al.
The Journal of Biological Chemistry|April 5, 2000
Electrospray ionization/mass spectrometric analyses of human promonocytic U937 cell glycerolipids and evidence that differentiation is associated with membrane lipid composition changes that facilitate phospholipase A2 activationF F Hsu, Z Ma, M Wohltmann, et al.
Biochemistry|April 30, 1996
Evidence for association of an ATP-stimulatable Ca(2+)-independent phospholipase A2 from pancreatic islets and HIT insulinoma cells with a phosphofructokinase-like proteinS Ramanadham, M J Wolf, Z Ma, et al.
Biochimica Et Biophysica Acta|July 27, 2001
A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cellsF Ghomashchi, A Stewart, Y Hefner, et al.
The Journal of Biological Chemistry|January 12, 1996
Interleukin-1 enhances pancreatic islet arachidonic acid 12-lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanismZ Ma, S Ramanadham, J A Corbett, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|July 11, 1997
Interleukin-1 reduces the glycolytic utilization of glucose by pancreatic islets and reduces glucokinase mRNA content and protein synthesis by a nitric oxide-dependent mechanismZ Ma, M Landt, A Bohrer, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Vanadium and diabetes]G Cros, J J Mongold, J J Serrano, et al.
Biological Trace Element Research|August 1, 1991
The distribution and half-life for retention of vanadium in the organs of normal and diabetic rats orally fed vanadium(IV) and vanadium(V)S Ramanadham, C Heyliger, M J Gresser, et al.
Canadian Journal of Physiology and Pharmacology|April 1, 1990
Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulinS Ramanadham, G H Cros, J J Mongold, et al.
Metabolism: Clinical and Experimental|October 1, 1989
Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatmentS Ramanadham, R W Brownsey, G H Cros, et al.
Lipids|September 13, 2000
Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty ratsF F Hsu, A Bohrer, M Wohltmann, et al.
The Journal of Biological Chemistry|April 5, 2000
Electrospray ionization/mass spectrometric analyses of human promonocytic U937 cell glycerolipids and evidence that differentiation is associated with membrane lipid composition changes that facilitate phospholipase A2 activationF F Hsu, Z Ma, M Wohltmann, et al.
Biochemistry|April 30, 1996
Evidence for association of an ATP-stimulatable Ca(2+)-independent phospholipase A2 from pancreatic islets and HIT insulinoma cells with a phosphofructokinase-like proteinS Ramanadham, M J Wolf, Z Ma, et al.
Biochimica Et Biophysica Acta|July 27, 2001
A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cellsF Ghomashchi, A Stewart, Y Hefner, et al.
The Journal of Biological Chemistry|January 12, 1996
Interleukin-1 enhances pancreatic islet arachidonic acid 12-lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanismZ Ma, S Ramanadham, J A Corbett, et al.
Pageof 7